13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SC Filed 2024-10-08 Event — SEC 0000921895-24-002262 →

BIOTECHNOLOGY VALUE FUND L P MoonLake Immunotherapeutics MLTX

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
3 13D/G filings on this issuer
2 other filings besides this one
Filer Track Record
31 filings by this filer
30 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 7.78
7,757,169 shares short · +6.1% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $10.18M
Point72 Asset Mgmt

Other 13D/G Filings on MoonLake Immunotherapeutics

FiledFormFilerStakeShares
2026-04-02 SCHEDULE 13D/A BIOTECHNOLOGY VALUE FUND L P 22.30% 8,302,735 view →
2023-06-30 SC BIOTECHNOLOGY VALUE FUND L P view →

Other Filings by BIOTECHNOLOGY VALUE FUND L P

FiledFormIssuerStakeShares
2026-04-02 SCHEDULE 13D/A MoonLake Immunotherapeutics MLTX 22.30% 8,302,735 view →
2025-11-24 SCHEDULE Repare Therapeutics Inc. 24.00% 10,333,600 view →
2025-05-20 SCHEDULE XOMA Royalty Corp XOMAP 21.60% 2,590,303 view →
2025-01-28 SCHEDULE XOMA Royalty Corp XOMAP 25.30% 2,983,026 view →
2024-07-19 SC Inventiva S.A. IVEVF view →
2024-01-29 SC Rain Oncology Inc. view →
2024-01-09 SC Kymera Therapeutics, Inc. KYMR view →
2023-12-18 SC Rain Oncology Inc. view →
2023-06-30 SC MoonLake Immunotherapeutics MLTX view →
2022-01-11 SC Rain Therapeutics Inc. view →
2021-09-15 SC Rain Therapeutics Inc. view →
2021-07-06 SC Rain Therapeutics Inc. view →
2021-05-25 SC Rain Therapeutics Inc. view →
2021-04-02 SC XOMA Corp XOMAP view →
2021-02-16 SC INFINITY PHARMACEUTICALS, INC. view →
2021-01-26 SC INFINITY PHARMACEUTICALS, INC. view →
2021-01-12 SC Erytech Pharma S.A. view →
2020-12-15 SC XOMA Corp XOMAP view →
2020-11-13 SC FIVE PRIME THERAPEUTICS, INC. view →
2020-11-12 SC INFINITY PHARMACEUTICALS, INC. view →
Showing 20 of 30

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →